XML 37 R29.htm IDEA: XBRL DOCUMENT v3.26.1
Stockholders' Equity (Tables)
6 Months Ended
Mar. 31, 2026
Stockholders' Equity Note [Abstract]  
Schedule of stockholders' equity

The changes in stockholders’ equity for the prior year comparable period are as follows:

 

 

 

 

 

 

Additional

 

 

 

 

 

Accumulated
Other

 

 

 

 

 

 

Common Stock

 

Paid-in

 

Treasury Stock

 

Comprehensive

 

Retained

 

 

 

 

Shares

 

Amount

 

Capital

 

Shares

 

Amount

 

Loss

 

Earnings

 

Total

 

Balance at September 30, 2024

 

36,707,840

 

$

37

 

$

275,771

 

 

(6,015,496

)

$

(93,854

)

$

(9,427

)

$

10,033

 

$

182,560

 

Net income

 

 

 

 

 

 

 

 

 

 

 

 

 

5,810

 

 

5,810

 

Exercise of stock options, grants of restricted stock awards, and vesting of restricted stock units

 

138,838

 

 

 

 

114

 

 

 

 

 

 

 

 

 

 

114

 

Taxes paid associated with net settlement of stock compensation awards

 

(30,575

)

 

 

 

(883

)

 

 

 

 

 

 

 

 

 

(883

)

Forfeitures of restricted stock awards

 

(22,500

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Shares swapped to exercise stock options

 

 

 

 

 

19

 

 

(582

)

 

(19

)

 

 

 

 

 

 

Stock compensation expense

 

 

 

 

 

3,431

 

 

 

 

 

 

 

 

 

 

3,431

 

Foreign currency translation and other

 

 

 

 

 

 

 

 

 

 

 

(1,871

)

 

 

 

(1,871

)

Balance at December 31, 2024

 

36,793,603

 

$

37

 

$

278,452

 

 

(6,016,078

)

$

(93,873

)

$

(11,298

)

$

15,843

 

$

189,161

 

Net income

 

 

 

 

 

 

 

 

 

 

 

 

 

7,051

 

 

7,051

 

Exercise of common stock options, grants of restricted stock awards, and vesting of restricted stock units

 

522,121

 

 

 

 

78

 

 

 

 

 

 

 

 

 

 

78

 

Taxes paid associated with net settlement of stock compensation awards

 

(119,819

)

 

 

 

(3,957

)

 

 

 

 

 

 

 

 

 

(3,957

)

Acquisition consideration paid in common stock (Note 3)

 

27,260

 

 

 

 

945

 

 

 

 

 

 

 

 

 

 

945

 

Shares swapped to exercise stock options

 

 

 

 

 

28

 

 

(815

)

 

(28

)

 

 

 

 

 

 

Stock compensation expense

 

 

 

 

 

2,578

 

 

 

 

 

 

 

 

 

 

2,578

 

Foreign currency translation

 

 

 

 

 

 

 

 

 

 

 

469

 

 

 

 

469

 

Balance at March 31, 2025

 

37,223,165

 

$

37

 

$

278,124

 

 

(6,016,893

)

$

(93,901

)

$

(10,829

)

$

22,894

 

$

196,325

 

Summary of share-based compensation expense

The table below presents the components of share-based compensation expense (in thousands):

 

 

 

Three Months Ended March 31,

 

 

Six Months Ended March 31,

 

 

 

2026

 

 

2025

 

 

2026

 

 

2025

 

Equity-classified awards:

 

 

 

 

 

 

 

 

 

 

 

 

Stock options

 

$

677

 

 

$

373

 

 

$

1,726

 

 

$

1,032

 

RSUs & RSAs

 

 

3,673

 

 

 

2,205

 

 

 

8,798

 

 

 

4,978

 

Total Equity-classified awards

 

$

4,350

 

 

$

2,578

 

 

$

10,524

 

 

$

6,010

 

The table below presents the components of share-based compensation expense by line-item within our Condensed Consolidated Statements of Operations (in thousands):

 

 

 

Three Months Ended March 31,

 

 

Six Months Ended March 31,

 

 

 

2026

 

 

2025

 

 

2026

 

 

2025

 

Stock compensation expense by function

 

 

 

 

 

 

 

 

 

 

 

 

Technology and operations

 

$

682

 

 

$

427

 

 

$

1,623

 

 

$

978

 

Sales and marketing

 

 

1,427

 

 

 

853

 

 

 

3,333

 

 

 

1,875

 

General and administrative

 

 

2,241

 

 

 

1,298

 

 

 

5,568

 

 

 

3,157

 

Total stock compensation expense:

 

$

4,350

 

 

$

2,578

 

 

$

10,524

 

 

$

6,010

 

Summary of stock options and restricted stock granted

The following table presents stock option and RSUs & RSAs grant activity:

 



 

Six Months Ended March 31,2026

 

Stock Options granted:

 



 

Options containing only service conditions:

 

 

167,800

 

Weighted average exercise price

 

$

24.52

 

Weighted average grant date fair value

 

$

10.44

 



 



 

Options containing performance conditions:

 

 

167,800

 

Weighted average exercise price

 

$

24.52

 

Weighted average grant date fair value

 

$

10.44

 



 



 

RSUs & RSAs granted:

 



 

RSUs & RSAs containing only service conditions:

 

 

356,650

 

Weighted average grant date fair value

 

$

27.21

 



 



 

RSUs & RSAs containing performance conditions:

 

 

307,800

 

Weighted average grant date fair value

 

$

26.58

 

Summary of fair value assumptions, stock options

The range of assumptions used to determine the fair value of stock options using the Black-Scholes option-pricing model during the six months ended March 31, 2026, were as follows:

 

 

 

Six Months Ended

 

 

 

March 31, 2026

 

Dividend yield

 

 

 

Expected volatility

 

45.93% - 53.51%

 

Risk-free interest rate

 

3.64% - 3.67%

 

Expected term

 

4.41 - 5.0 years